Colony Bankcorp, Inc.
NYSE:CBANBanks - Regional
+$0.01 today
- Market cap
- $542.11M
- Beta
- 0.55
- P/E (TTM)
- 14.6
- EPS (TTM)
- $1.41
- Dividend yield
- 2.29%
Volume 0.25M
Average 0.31M
CBAN Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Colony Bankcorp, Inc.NYSE: CBAN
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $17.44M rose 8.5% year over year, ahead of the -3.7% change in trailing-twelve-month cost of revenue. Sequentially, it rose 17.5% from the prior quarter. Over 3 fiscal years it compounded at +63.8% a year.
Context
- Cost of revenue amounted to 33.6% of revenue in FY2025, down 2.7 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +8.5% holds above the trailing-twelve-month pace of -3.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 62.55M USD
- Year-over-year change
- -2.6%
- 4-year CAGR
- +87.2%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 62.55M | -2.6% |
| FY2024 | 2024-12-31 | 64.22M | +27.7% |
| FY2023 | 2023-12-31 | 50.27M | +253.2% |
| FY2022 | 2022-12-31 | 14.24M | +179.3% |
| FY2021 | 2021-12-31 | 5.1M | — |
Cost of Revenue vs competitors
How CBAN compares with its peers on the latest reported figures
- CBAN's LTM Mar 2026 cost of revenue of $62.27M is the 4th highest of the 11 companies compared; the peer median is $54.95M.
- Its year-over-year change of -3.7% is the 6th highest of 11, against a peer median of -2.5%.
- Cost of revenue amounts to 31.5% of revenue for CBAN, versus a peer median of 31.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $81.89M | -6.3% | +65.7% | 47.1% | |
| LTM Mar 2026 | $74.68M | +8.7% | +52.2% | 33.8% | |
| LTM Mar 2026 | $67.2M | +32.1% | +47.1% | 40.6% | |
| LTM Mar 2026 | $62.27M | -3.7% | +63.8% | 31.5% | |
| LTM Mar 2026 | $57.18M | -12.9% | +59.6% | 27.6% | |
| LTM Mar 2026 | $56.33M | -3.9% | +57.1% | 40.7% | |
| LTM Mar 2026 | $53.58M | -7.1% | +57.9% | 45.9% | |
| LTM Mar 2026 | $43.28M | +1.5% | +44.6% | 30.0% | |
| LTM Mar 2026 | $33.26M | -1.1% | +127.0% | 28.8% | |
| LTM Mar 2026 | $33.17M | -6.5% | +78.4% | 28.6% | |
| LTM Mar 2026 | $22.32M | +107.9% | +101.1% | 18.5% | |
| Peer median (excluding CBAN) | $54.95M | -2.5% | +58.7% | 31.9% | |
Competitors are the stored peer set for CBAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 106.88M | 126.56M | 160.55M | 176.62M | 186.11M |
| Cost of Revenue | 5.1M | 14.24M | 50.27M | 64.22M | 62.55M |
| Gross Profit | 101.78M | 112.33M | 110.28M | 112.4M | 123.56M |
| Gross Margin | 95.2% | 88.8% | 68.7% | 63.6% | 66.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 48.25M | 56.47M | 52.72M | 53.78M | 3.51M |
| Operating Expenses | 78.63M | 89.48M | 83.07M | 82.83M | 88.42M |
| Depreciation & Amortization | 8.63M | 11.63M | 8.7M | 8.13M | 93K |
| EBITDA | 31.78M | 34.48M | 35.92M | 37.7M | 35.14M |
| EBITDA Margin | 29.7% | 27.2% | 22.4% | 21.3% | 18.9% |
| Operating Income | 23.15M | 22.85M | 27.21M | 29.57M | 35.14M |
| Operating Margin | 21.7% | 18.1% | 16.9% | 16.7% | 18.9% |
| Interest Income | 70.59M | 91.49M | 124.92M | 137.24M | 149.95M |
| Interest Expense | 4.4M | 10.87M | 46.67M | 61.17M | 58.05M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 23.15M | 22.85M | 27.21M | 29.57M | 35.14M |
| Pre-Tax Margin | 21.7% | 18.1% | 16.9% | 16.7% | 18.9% |
| Income Tax Expense | 4.5M | 3.31M | 5.47M | 5.7M | 6.88M |
| Net Income | 18.66M | 19.54M | 21.75M | 23.87M | 28.25M |
| Net Margin | 17.5% | 15.4% | 13.5% | 13.5% | 15.2% |
| EPS (Basic) | 1.66 | 1.14 | 1.24 | 1.36 | 1.59 |
| EPS (Diluted) | 1.66 | 1.14 | 1.24 | 1.36 | 1.59 |
| Weighted Avg Shares | 11.25M | 17.19M | 17.58M | 17.56M | 17.79M |
| Weighted Avg Shares (Diluted) | 11.25M | 17.19M | 17.58M | 17.56M | 17.79M |
Colony Bankcorp, Inc.
NYSE:CBAN
Intrinsic Alpha fair value
Locked
Current Price
$19.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.